Cephalon, Mylan Settle Patent Dispute Over Provigil
Cephalon Inc. has settled a patent dispute with a fourth potential competitor, part of its ongoing efforts to delay generic production of the narcolepsy drug Provigil....To view the full article, register now.
Already a subscriber? Click here to view full article